Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_3
1
17%
Ph phase_2
1
17%
Ph phase_4
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

completed467%
active_not_recruiting117%
not_yet_recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruitingphase_4

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

NCT06709313
not_yet_recruitingphase_3

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

NCT06405243
completednot_applicable

Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life

NCT05573607
completednot_applicable

Effect of Chromium Supplementation on Intracytoplasmatic Sperm Injection (ICSI) Outcomes in Polycystic Ovary Syndrome Ladies

NCT03503201
completednot_applicable

Chromium and Insulin Resistance

NCT00846248
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06709313Phase 4

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

Active Not Recruiting
NCT06405243Phase 3

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

Not Yet Recruiting
NCT05573607Not Applicable

Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life

Completed
NCT03503201Not Applicable

Effect of Chromium Supplementation on Intracytoplasmatic Sperm Injection (ICSI) Outcomes in Polycystic Ovary Syndrome Ladies

Completed
NCT00846248Not Applicable

Chromium and Insulin Resistance

Completed
NCT00067626Phase 2

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

Completed

All 6 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6